Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer.
Sanz-Santos J, Serra P, Andreo F, Llatjós M, Castellà E, Monsó E.
BMC Cancer. 2012 Jan 21;12:34. doi: 10.1186/1471-2407-12-34.
Related citations
Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Ito M, Niho S, Nihei K, Yoh K, Ohmatsu H, Ohe Y.
BMC Cancer. 2012 Jan 20;12:27.
A population-based cohort study of chest x-ray screening in smokers: lung cancer detection findings and follow-up.
Dominioni L, Rotolo N, Mantovani W, Poli A, Pisani S, Conti V, Paolucci M, Sessa F, Paddeu A, D'Ambrosio V, Imperatori A.
BMC Cancer. 2012 Jan 17;12:18. doi: 10.1186/1471-2407-12-18.
Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life.
Schuette W, Tesch H, Büttner H, Krause T, Soldatenkova V, Stoffregen C.
BMC Cancer. 2012 Jan 13;12:14.
Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
Kupert E, Anderson M, Liu Y, Succop P, Levin L, Wang J, Wikenheiser-brokamp K, Chen P, Pinney SM, Macdonald T, Dong Z, Starnes S, Lu S.
BMC Cancer. 2011 Dec 9;11:513.
Paraneoplastic syndrome mimicking adult-onset Still's disease caused by advanced lung cancer: a case report.
Wu N, Li Q, Gu CX, Ahmed T, Yao XP.
BMC Cancer. 2011 Nov 16;11:487.
Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y.
BMC Cancer. 2011 Oct 25;11:459.
TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X, Liao Z, Ma H, Qian J, Liu Z, Yuan X, Gomez D, Komaki R, Wang LE, Wei Q.
BMC Cancer. 2011 Oct 14;11:447.
The effect of breast cancer awareness month on internet search activity--a comparison with awareness campaigns for lung and prostate cancer.
Glynn RW, Kelly JC, Coffey N, Sweeney KJ, Kerin MJ.
BMC Cancer. 2011 Oct 12;11:442.
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer.
Wu YL, Park K, Soo RA, Sun Y, Tyroller K, Wages D, Ely G, Yang JC, Mok T.
BMC Cancer. 2011 Oct 7;11:430.
Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study.
Zhu W, Liu X, He J, Chen D, Hunag Y, Zhang YK.
BMC Cancer. 2011 Sep 15;11:393.
Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, Jiang F.
BMC Cancer. 2011 Aug 24;11:374.
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01).
Kawahara M, Tada H, Tokoro A, Teramukai S, Origasa H, Kubota K, Shinkai T, Fukushima M, Furuse K.
BMC Cancer. 2011 Aug 17;11:356.
Quality of life assessment as a predictor of survival in non-small cell lung cancer.
Braun DP, Gupta D, Staren ED.
BMC Cancer. 2011 Aug 15;11:353.
Prognostic significance of CD44s expression in resected non-small cell lung cancer.
Ko YH, Won HS, Jeon EK, Hong SH, Roh SY, Hong YS, Byun JH, Jung CK, Kang JH.
BMC Cancer. 2011 Aug 7;11:340.
Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.
Yu L, Hales CA.
BMC Cancer. 2011 Aug 3;11:331.
5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
Xie ZH, Quan MF, Liu F, Cao JG, Zhang JS.
BMC Cancer. 2011 Jul 29;11:322.
Lung cancer in HIV patients and their parents: a Danish cohort study.
Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, Obel N.
BMC Cancer. 2011 Jun 25;11:272.
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.
Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, Mah V, Rivera-Pazos CM, Chatterjee D, Vega MI, Maresh EL, Horvath S, Chia D, Bonavida B, Goodglick L.
BMC Cancer. 2011 Jun 21;11:259.
Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals.
Wu NY, Cheng HC, Ko JS, Cheng YC, Lin PW, Lin WC, Chang CY, Liou DM.
BMC Cancer. 2011 Jun 13;11:242.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on